Steve Martin is now serving in a new board position at Ensysce Biosciences, Inc.

Sep 13, 2020
Board and Executive Moves
Background Information
Ensysce Biosciences, Inc. supplies drugs for pain and cancer markets. Its technologies include opioid drug abuse-resistant, single-walled carbon nanotubes, SWCNT-immuno and gene therapy and BIO-MD prodrug technology. The company was founded by Bob G. Gower and William H.C. Chang in 2008 and is headquartered in San Diego, CA.